Ignite Creation Date:
2024-05-05 @ 11:27 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01330784
Status:
COMPLETED
Last Update Posted:
2011-04-07
First Post:
2011-04-06
Brief Title:
Assessment of the Therapeutic Utility of hMG-HP
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
Assessment of the Therapeutic Utility of hMG-HP Within a Protocol of Controlled Ovarian Hyperstimulation in IVF in Normoresponders Women Undergoing Downregulation With GnRH Antagonist
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the effectiveness of a protocol of ovarian hyperstimulation with urinary gonadotrophins to achieve clinical pregnancy in females undergoing IVF
Study hypothesis to assess the effectiveness of a protocol of urinary gonadotrophins
Study hypothesis to assess the effectiveness of a protocol of urinary gonadotrophins
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None